May 25, 2018
Rising pharmaceutical star Kronos Bio has signed a major deal with biotech celebrity Norbert Bischofberger, booking him as the inaugural CEO for their big screen debut. And when we say "big screen," we mean it. Building on the high-throughput screening techniques developed in the laboratory of founding scientist and KI member Angela Koehler, the company aims to discover and develop novel therapies to target the most intractable and challenging cancer targets—the so-called "undruggable" transcription factors. With their stellar crew and private lot in Lab Central, Kronos Bio is well poised to be a therapeutic blockbuster.